Chemical Business Newsbase articles from June 2010

Chemical Business Newsbase archives from June 2010

Orphan drug designation (10 Jun 2010): EU/3/10/733 (Glyceryl tri-(4-phenylbutyrate), Hyperion Therapeutics).
June 30, 2010... On 15 Jun 2010, the European Commission (EC) announced decision number C(2010)3903 of 10 Jun 2010, the approval of EU orphan drug designation EU/3/10/733. The active ingredient is glyceryl tri-(4-phenylbutyrate) and the product is indicated for...

Birla Corp plans cement mixing plant at Kota.
June 30, 2010... Birla Corp is planning to establish a cement mixing and packing unit having 3 lakh tonnes/y capacity at Kota, India. The company is also increasing the grinding capacity of Durgapur, India unit to 2.3 M tonnes/y by adding 6 lakh tonnes of...

Investment Column: Vedanta Resources.(Column)
June 30, 2010... If there were a "nasty company of the year" award, the FTSE-100 listed mining group Vedanta Resources would not be short of nominations. Human rights and environmental activists consistently attack Vedanta for its practices, not least its...

Emission cuts threatened by economic recovery.
June 30, 2010... Britain is not on course to meet its climate change targets for reducing carbon emissions, the Government is bluntly warned on 30 Jun 2010. Only a step change in effort, brought about by a range of new policies ranging from boosting numbers of...

Pasteuria usgae; exemption from the requirement of a tolerance.
June 30, 2010... This regulation, issued by the US Environmental Protection Agency (EPA), establishes an exemption from the requirement of a tolerance for residues of the microbial pesticide, Pasteuria usgae, in or on all food commodities when applied preharvest...

Formaldehyde gas; receipt of application for emergency exemption, solicitation of public comment.
June 30, 2010... The US Environmental Protection Agency (EPA) has received a quarantine exemption request from the EPA's Office of Emergency Management, Office of Solid Waste and Emergency Response (OSWER) to use formaldehyde gas (CAS No 82115-62-6) to...

1-Naphthaleneacetic acid; time-limited tolerance, technical correction.
June 30, 2010... The US Environmental Protection Agency (EPA) issued a final rule in the Federal Register of 11 Sep 2009 (74 FR 46689) (FRL-8426-2) concerning azinphos-methyl, disulfoton, esfenvalerate, ethylene oxide, fenvalerate, et al, tolerance actions. This...

Lauryl sulfate salts; antimicrobial registration review final work plan and proposed registration review decision; notice of availability.
June 30, 2010... This notice, issued by the US Environmental Protection Agency (EPA), announces the availability of the EPA's final work plan and proposed registration review decision for the pesticide lauryl sulfate salts and opens a public comment period on...

EU cuts duty on Jindal Poly product.
June 30, 2010... The European Union (EU) has reduced the anti-dumping duty on imports of polyethylene terephthalate film made by the Indian firm Jindal Poly Films Ltd from 17.1% to 8.4%, as the level of subsidisation to Jindal Poly Films has decreased.

Costlier fuel puts pressure on drug prices: Companies may review cost structure in 3-6 months.
June 30, 2010... Analysts opine that the hike in prices of diesel has pressurised drug prices. Pharma industry opines that the increase in transportation and energy costs, due to increase in diesel price, will make the pharma companies to revise the prices of...

Emami signs deal to buy manufacturing unit in Egypt: To set up plant in Bangladesh by Oct 2010.
June 30, 2010... Emami Ltd has signed an agreement to buy a small personal care products manufacturing unit in Egypt for Rup 30 crores. The deal is subject to mandatory approvals. The company proposes to acquire some local FMCG brands and another manufacturing...

Natco's Anastrazole generic in US.
June 30, 2010... The Hyderabad-based Natco Pharma Ltd has introduced the generic version of anastrazole 1 mg tablet in the US market, following the final approval granted by the United States Food and Drug Administration. Natco has launched anastrazole, used to...

New and generic drug approvals: Methadone Hydrochloride Oral Solution, Vistapharm. [2 tables in original article].
June 30, 2010... On 30 Jun 2010, the US Food and Drug Administration announced approval of ANDA 090707 for Methadone Hydrochloride Oral Solution. The product contains methadone hydrochloride at 5mg/5ml or 10mg/5ml, is manufactured by Vistapharm, and is...

New and generic drug approvals: Heparin Sodium Injection, Sagent Pharms. [3 tables in original article].
June 30, 2010... On 30 Jun 2010, the US Food and Drug Administration announced approval of ANDA 090808 for Heparin Sodium Injection. The product contains heparin sodium at 1000 units/ml, 5000 units/ml, or 10,000 units/ml, is manufactured by Sagent Pharms, and is...

New and generic drug approvals: Heparin Sodium Injection, Sagent Pharms. [1 table in original article].
June 30, 2010... On 30 Jun 2010, the US Food and Drug Administration announced approval of ANDA 090809 for Heparin Sodium Injection. The product contains heparin sodium at 20,000 units/ml, is manufactured by Sagent Pharms, and is prescription only. There are two...

New and generic drug approvals: Heparin Sodium Preservative Free Injection, Sagent Pharms. [1 table in original article].
June 30, 2010... On 30 Jun 2010, the US Food and Drug Administration announced approval of ANDA 090810 for Heparin Sodium Preservative Free Injection. The product contains heparin sodium at 1000 units/ml, is manufactured by Sagent Pharms, and is prescription...

New and generic drug approvals: Adapalene Topical Cream, Nycomed US. [1 table in original article].
June 30, 2010... On 30 Jun 2010, the US Food and Drug Administration announced approval of ANDA 090824 for Adapalene Topical Cream. The product contains adapalene at 0.1%, is manufactured by Nycomed US, and is prescription only. There is one therapeutic...

Brazil Sao Martinho plans to store 76% of 2010/11 ethanol production.
June 30, 2010... Brazilian sugar and ethanol producer Sao Martinho has planned to utilize maximum ethanol storage capacity of 462 M lt by 2010-2011 internally, which accounts 76% of the company's production output. The company forecasted the expected ethanol...

New light stabilizer extends agricultural film life.
June 30, 2010... According to United Nations estimates, over 9 bn people will be living on Earth by the year 2050. The amount of arable land needed to feed them, however, will not increase at the same rate. Inexpensive greenhouses made from plastic film...

BioSante Pharmaceuticals announces positive clinical results in Pill Plus oral contraceptive study.(Clinical report)
June 30, 2010... On 30 Jun 2010 BioSante Pharmaceuticals Inc announced positive results from a Phase II study of the Pill-Plus triple hormone oral contraceptive. Results showed an increase in the frequency of sexual activity and reduced frequency of rejection of...

Solutia's performance films segment receives grant to invest in energy-efficient building technologies.
June 30, 2010... Solutia Inc is pleased to announce that its performance films segment was awarded a $356,000 American Recovery and Reinvestment Act (ARRA) grant, entitled Recovery Act: Advanced Energy Efficient Building Technologies, from the US Department of...

GW and Otsuka agree three year extension to global cannabinoid research collaboration.
June 30, 2010... GW Pharmaceuticals Plc and Otsuka Pharmaceutical Co Ltd announce on 30 Jun 2010 that they have signed a three year extension to their global cannabinoid research collaboration. This collaboration was originally signed in Jul 2007 with a three...

SGL Group and Hitachi Chemical agree on further cooperation for lithium-ion batteries in Europe.
June 30, 2010... SGL Group and Hitachi Chemical Co Ltd announce to extend their comprehensive and mutual cooperation to supply anode material solutions for lithium-ion batteries for the European automotive and industrial markets. SGL Group and Hitachi Chemical...

Chelsea Therapeutics Inc achieves target enrolment in Phase III trial of northera in neurogenic orthostatic hypotension.
June 30, 2010... Chelsea Therapeutics International Ltd has successfully reached its target enrolment of 150 patients in its Northera (Droxidopa) pivotal Phase III Study 301 for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH). Results from...

XOMA achieves planned enrolment goal for Phase IIb clinical trial of XOMA 052 in Type 2 diabetes.
June 30, 2010... XOMA Ltd, a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrolment goal of 325 patients for its Phase IIb dose-ranging clinical trial of XOMA 052, and that it expects patient enrolment to...

INVO Bioscience announces the initial results and the first INVO baby in Peru.(Financial report)
June 30, 2010... INVO Bioscience Inc, a medical device company focused on treatment options for patients diagnosed with infertility, announced that pregnancy results were released at the European Society of Human Reproduction & Embryology (ESHRE), a...

Transition Therapeutics announces initiation of a Phase I clinical study of TT-301.
June 30, 2010... Transition Therapeutics Inc (Transition) has announced that the first patient has been dosed with drug candidate TT-301 in a Phase I clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in pre-clinical models of...

Oxycyte PFCE decreases mortality from decompression sickness in pre-clinical study.
June 30, 2010... Oxygen Biotherapeutics Inc has announced that results from US Navy studies demonstrated decreased mortality in porcine animal models that were given an intravenous dose of Oxycyte perfluorocarbon emulsion (PFCE) after the onset of decompression...

Rubicon Genomics Inc's Picoplex Linear Amplification Technology enables successful international clinical genetic study of single human cells.(Clinical report)
June 30, 2010... Rubicon Genomics Inc (Rubicon) has announced that its PicoPlex linear whole genome amplification technology was proven to be effective in an independent clinical study organized by the European Society for Human Reproduction and Embryology...

MethylGene further extends collaboration with Otsuka Pharmaceutical Co Ltd for the development of kinase inhibitors for treatment of ocular diseases.
June 30, 2010... MethylGene Inc announced that Otsuka Pharmaceutical Co Ltd (Otsuka) has further extended its funded research collaboration with MethylGene for the development of novel, small molecule kinase inhibitors for the local delivery and treatment of...

Axxess Pharma Inc nears completion of exclusive license agreement to globally market and distribute high potency Vitamin D-3 to help reduce bone loss and joint pain.
June 30, 2010... Axxess Pharma Inc is pleased to announce they are in the final stages of signing an exclusive license agreement to market and distribute a high potency, highly concentrated vitamin D-3 capsule. This vitamin can be taken once a week in adjunct...

GeneNews executes marketing partnership agreement with GeneDiagnostics Inc.
June 30, 2010... GeneNews Ltd announced that it has executed a formal marketing partnership agreement with GeneDiagnostics Inc (GD) to market ColonSentry, the world's first blood-based test to determine a person's current risk for colorectal cancer, in China....

China Nuokang Bio-Pharmaceutical Inc, announces agreement to market Dianatal Obstetric Gel in Greater China Region.
June 30, 2010... China Nuokang Bio-Pharmaceutical Inc,(Nuokang), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sale of hospital-based medical products, announced that it has signed an agreement...

Biocitech SAS welcomes new researchers from Pharma Omnium International.
June 30, 2010... Biocitech, the Paris life science technology park, announces the amalgamation on its campus of the anti-infective research teams of Pharma Omnium International, a leading French pharmaceutical company specialized in research into...

Cannabis Science Inc, begins expansion of production and research at Montana Pain Management.
June 30, 2010... Cannabis Science Inc, a pioneering US biotech company developing pharmaceutical cannabis products, has begun the process of expanding the internal production and research capabilities of Missoula medical cannabis provider, Montana Pain...

Sanofi to set up new facility in Saudi Arabia.
June 30, 2010... Sanofi-Aventis will build a new manufacturing plant in King Abdullah Economic City (KAEC) in Saudi Arabia through an agreement with the Emaar development company (ECC). The 35,000 sq m facility will produce oral anti-diabetics and cardiovascular...

Incentives help keep Pfizer centre in Richmond.
June 30, 2010... City and state officials offered a package of incentives to Pfizer Inc, to keep its research and development centre in Richmond and preserve more than 300 local jobs. The pharmaceutical company, which in May 2010 announced plans to close a...

Unblinded Phase IIa clinical trial data delivers excellent results for Novexatin, NovaBiotics Ltd lead product candidate for the treatment of fungal nail infection.
June 30, 2010... NovaBiotics announces the initial unblinded results from its Phase IIa clinical study for Novexatin. All study end-points were met in the trial, which had been designed to assess the safety and tolerability of the novel antifungal drug...

Northwest Biotherapeutics: Expert available to discuss the emergence of personalized vaccines with unprecedented efficacy made from one's own cancer cells.
June 30, 2010... Many have tried, and failed, attempting to develop personalized immune therapies for cancer. Northwest Biotheraputics, however, is an industry leading company at the forefront, now making such immunotherapies a reality. The company has developed...

Raptor Pharmaceutical Inc announces license agreement with Uni Pharma Co Ltd for Convivia.
June 30, 2010... Raptor Pharmaceutical Corp (Raptor) announced that it has entered into an exclusive agreement with Uni Pharma Co Ltd to commercialize Convivia, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan. (Full text).

GW Pharmaceuticals and Otsuka Pharmaceutical Co Ltd agree three year extension to global cannabinoid research collaboration.
June 30, 2010... GW Pharmaceuticals plc (GW) and Otsuka Pharmaceutical Co Ltd (Otsuka) announce that they have signed a three year extension to their global cannabinoid research collaboration. This collaboration was originally signed in Jul 2007 with a three...

SciClone Pharmaceuticals Inc and Sigma-Tau Finanziaria SpA announce final data from clinical trial of Zadaxin as H1N1 vaccine enhancer.(Clinical report)
June 30, 2010... SciClone Pharmaceuticals Inc (SciClone) and its partner Sigma-Tau SpA, announced final results from a clinical study evaluating the potential of Zadaxin (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent...

Futura Medical signs development agreement with GlaxoSmithKline (GSK) for TPR100.
June 30, 2010... Futura Medical plc announces that it has signed a development agreement with GlaxoSmithKline Consumer Healthcare (GSK) for the development of TPR100, the company's novel, topically applied product for pain relief. Under the terms of the...

China Nuokang Bio-Pharmaceutical Inc announces agreement to market Dianatal obstetric gel in Greater China region.
June 30, 2010... China Nuokang Bio-Pharmaceutical Inc (Nuokang) announced that it has signed an agreement with the Swiss company, HCB Happy Child Birth Holding Inc (HCB), to register and market Dianatal Obstetric Gel, a unique product developed in Switzerland to...

OctoPlus announces agreement with a major pharmaceutical company Novartis Corp on its controlled release technology.
June 30, 2010... OctoPlus NV announces that it has signed an agreement with Novartis relating to the use of OctoPlus' controlled release technology. Under the contract announced, OctoPlus will develop, up to in vivo feasibility, a controlled release formulation...

Monsanto Company launches Warrant Herbicide.
June 30, 2010... Monsanto Company (Monsanto) announces the launch of a new encapsulated formulation of acetochlor designed for cotton and soybean acres in 2010 has proven successful. The new product was used as MON 63410 Herbicide by farmers this season and will...

Global Alumina announces joint venture budget approval.
June 30, 2010... Global Alumina Corp (Global Alumina), a corporation participating in a joint venture to develop an alumina refinery, mine and associated infrastructure in the bauxite-rich region of the Republic of Guinea , announced that the joint venture board...

Terra Systems Inc receives start up funding.
June 30, 2010... Terra Systems Inc (Terra Systems) announced that it has received a grant as a part of an alliance formed with the Utah State University Research Foundation and its Energy Dynamics Laboratory to fund the start up of its carbon pilot plant. Terra...

Exxaro and Tronox announce successful commissioning of the expansion of the tiwest titanium dioxide plant in Kwinana, Western Australia.
June 30, 2010... Exxaro Resources Ltd (Exxaro) and Tronox Inc (Tronox) announced that the joint venture has successfully commissioned the Tiwest Kwinana titanium dioxide (TiO2) pigment plant expansion project and is ready to commence production and ramp-up of...

Advanced Life Sciences submits updated special protocol assessment to FDA for Restanza in community Acquired Bacterial Pneumonia.
June 30, 2010... Advanced Life Sciences Holdings Inc (Advanced Life Sciences), a biopharmaceutical company developing Restanza, a novel once-a-day oral antibiotic, announced that it has submitted a final Special Protocol Assessment (SPA) with the FDA for the...

Paramount Energy Trust converts into Perpetual Energy Inc, updates gas storage funding and announces management addition.
June 30, 2010... Perpetual Energy Inc (Perpetual) announced that it has completed the previously announced plan of arrangement involving Perpetual, Paramount Energy Trust and Paramount Energy Operating Corp, pursuant to which the Trust converted into the Corp....

EntreMed announces reverse stock split.
June 30, 2010... EntreMed Inc has announced that it has filed a certificate of amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-11 reverse stock split that will become effective with the open of trading on 1 Jul 2010. The...

Martek Biosciences announces restructuring plans for winchester, KY, manufacturing site.
June 30, 2010... Martek Biosciences Corp (Martek) has announced that it plans to restructure its Winchester, KY, manufacturing facilities in an effort to streamline operations, improve capacity utilization, and reduce manufacturing costs and operating expenses....

Shire purchases strategic site in Massachusetts.
June 30, 2010... Shire plc has announced its purchase of the Lexington Technology Park campus in Lexington, MA. The purchase signifies an investment in the growth of its Human Genetic Therapies business, which focuses on the discovery, development, and...

Celsis seeks injunction against Invitrogen for LiverPool patent infringement.
June 30, 2010... Celsis In Vitro Inc (Celsis) has announced that it has filed a patent infringement lawsuit against Invitrogen Corp and CellzDirect Inc in the US District Court for the Northern District of Illinois in Chicago and has moved for a preliminary...

Sanofi-aventis to acquire TargeGen Inc.
June 30, 2010... TargeGen Inc has announced that the company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560 M if such milestones...

Biospherics acquires global patent rights from University of Kentucky Research Foundation to develop tagatose as a trigylcerides therapy.
June 30, 2010... Spherix Inc has announced that its wholly-owned subsidiary, Biospherics Inc, has signed a licence agreement with the University of Kentucky Research Foundation (UKRF). The agreement gives Biospherics the worldwide rights to international patents...

AMS receives 510(k) clearance of its revolutionary MoXy liquid cooled fibre for fast, safe treatment of enlarged prostate.
June 30, 2010... American Medical Systems (AMS) announced the 510(k) clearance of its revolutionary MoXy Liquid Cooled Fibre. Designed to be used with the recently launched GreenLight XPS (Xcelerated Performance System), the MoXy liquid-cooled fibre provides...

Neuralstem completes $10 M registered direct offering.
June 30, 2010... Neuralstem Inc announced registered direct offering of $10 M of units to institutional investors. The units were priced at $2.80 and consisted of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an...

OXIS International assumes control and exploitation rights to key L-ergothioneine patent filing representing a major market opportunity.
June 30, 2010... Oxis International Inc (Oxis) announced that it has assumed control and future exploitation rights to International Patent PCT Application PCY/US2008/059831. The invention centres on the use of L-Ergothioneine ('ERGO') as a primary preservative...

ULURU Inc announces licensing agreement for Altrazeal in China.
June 30, 2010... ULURU Inc announced that it has signed a licensing and supply agreement with Jiangxi Aiqilin Pharmaceuticals Group (Aiqilin) for the marketing of Altrazeal in China, including Hong Kong, Macau and Taiwan. Under the terms of the licensing and...

JHP Pharmaceuticals announces multi-year contract manufacturing agreement.
June 30, 2010... JHP Pharmaceuticals (JHP) announced that it has entered into a multi-year contract supply agreement with an undisclosed ophthalmic company. Under terms of the agreement, JHP will be responsible for manufacturing and supply of a proprietary...

Russia's breast cancer drug market will reach $226 M by 2014.
June 30, 2010... Decision Resources, forecasts that the breast cancer drug market in Russia will reach $226 M by 2014. Factors promoting the market's growth include steady increases in the incidence of postmenopausal breast cancer cases, a slight shift toward...

CBio announces clinical trial milestone.
June 30, 2010... CBio Ltd has announced the achievement of a recruitment milestone in its clinical trial of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid...

Adventrx announces 9-month stability data results for ANX-530.(Financial report)
June 30, 2010... Adventrx Pharmaceuticals Inc (Adventrx) has announced the results of stability tests performed on samples of ANX-530 (vinorelbine injectable emulsion), or Exelbine, manufactured at the company's intended commercial manufacturing site. The...

Ganeden Biotech and Glanbia Nutritionals develop new partnership integrating probiotics with micronutrient premixes.
June 30, 2010... Ganeden Biotech Inc (Ganeden) has announced a new partnership with Glanbia Nutritionals (Glanbia). Glanbia produces custom micronutrient premixes for the food, beverage, human health and personal care industries. Ganeden's booth at the IFT...

China BCT signs exclusive distribution contract with Liujiang County Chinese Medicine Hospital.
June 30, 2010... China BCT Pharmacy Group Inc (China BCT) has announced that the company has signed an exclusive pharmaceutical distribution contract with Liujiang County Chinese Medicine Hospital for a three-year period effective 1 Jul 2010. China BCT will...

Pharmalink AB closes deal with Grifols SA for the acquisition of the Xepol Programme for the treatment of post-polio syndrome.
June 30, 2010... Pharmalink AB has announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby...

Air Products to build new ASU at Granite City, IL.
June 30, 2010... Air Products has announced the signing of a new long-term oxygen and nitrogen supply agreement, and that it will build a new air separation unit (ASU) and refurbish its existing ASU and liquefier at its facility in Granite City, IL. The new...

Roche and IBM collaborate to develop nanopore-based DNA sequencing technology.
June 30, 2010... Roche announced an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM's recently published 'DNA Transistor' technology, the collaboration will take...

Burns & Levinson LLP files class action lawsuit against Matrixx.
June 30, 2010... Burns & Levinson LLP announced that a Massachusetts man filed a class action lawsuit in US District Court in Boston, claiming injuries including loss of sense of smell and diminished sense of taste as a result of using Zicam Cold Remedy Gel....

Ecolab launches first EPA-approved, ready-to-use hard surface disinfectant effective against clostridium difficile.
June 30, 2010... Ecolab Inc announced the launch of Virasept, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the US Environmental Protection Agency to be effective against Clostridium difficile spores. Clostridium...

Santarus announces launch of prescription Zegerid authorized generic and company restructuring.
June 30, 2010... Santarus Inc announced that pursuant to its distribution and supply agreement with Prasco LLC, Prasco is commencing shipments of an authorized generic of prescription Zegerid (omeprazole/ sodium bicarbonate) Capsules in 20 mg and 40 mg dosage...

Cubist Pharmaceuticals enrols first patient in CXA-201 Phase II study in complicated intra-abdominal infections.(Clinical report)
June 30, 2010... Cubist Pharmaceuticals Inc (Cubist) announced the enrolment of the first patient in a Phase II study with CXA-201. This multicentre, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active...

Sepracor reports preliminary results from a second Phase III study for OMNARIS HFA Nasal Aerosol in Seasonal Allergic Rhinitis.(Report)
June 30, 2010... Sepracor Inc announced the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent...

Research and Markets: Formulary advantages in osteoporosis: Rise and fall of access in the wake of Fosamax Generics, rebate and contracting efforts, and new drug launches.
June 30, 2010... Research and Markets has announced the addition of Decision Resources Inc's new report 'Formulary Forum: Formulary Advantages in Osteoporosis' to their offering. With 62 M cases of osteoporosis and osteopenia in US and a US market of over $3.8...

Gold Standard Diagnostics signs exclusive US distribution agreement with Axis-Shield for Homocysteine.
June 30, 2010... Gold Standard Diagnostics Inc (GSD) announced the execution of an agreement with Axis-Shield to distribute their proprietary assays in the US Market. Axis-Shield owns a number of patents in the areas of cardiovascular and neurodegenerative...

Aeolus Pharmaceuticals' AEOL 10150 protects lungs against mustard gas exposure in animal studies.
June 30, 2010... Aeolus Pharmaceuticals Inc (Aeolus) reported that researchers from National Jewish Health and Lovelace Respiratory Research Institute have completed a second study confirming that AEOL 10150 protects lungs from whole mustard gas exposure in...

TrendSetter Solar Products announces US manufacturing plan.
June 30, 2010... TrendSetter Solar Products Inc (TrendSetter) announced the company's intention to move its sourcing of thermal solar panel from China to the US. TrendSetter Solar Products Inc is a quality manufacturer of solar hot water heating and storage...

Vicept Therapeutics secures $10 M to complete Series A funding; company to develop lead product for rosacea and other topical agents for the treatment of skin disorders.
June 30, 2010... Vicept Therapeutics Inc (Vicept) announced that it has secured $10 M to complete a total $16 M Series A financing. The Series A was led by Vivo Ventures, Sofinnova Ventures and Fidelity Biosciences. Proceeds from the financing will be used to...

Response Genetics launches EML4-ALK genetic test in lung cancer.
June 30, 2010... Response Genetics Inc announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about 4% of tumours from patients with...

Doe & Ingalls of North Carolina facilities receives federal and state regulatory permits to supply controlled substances.
June 30, 2010... Doe & Ingalls of North Carolina is pleased to announce that its service centres in California, Florida, Maryland and North Carolina have received federal and state regulatory permits to supply controlled materials. Having these permits...

Dacogen (decitabine) for injection Phase III AML results announced.
June 30, 2010... SuperGen Inc announced that Eisai Inc released information regarding a randomized Phase III clinical trial of Dacogen (decitabine) for Injection in elderly patients with acute myeloid leukaemia (AML). The comparator in this trial was low-dose...

Calistoga Pharmaceuticals raises $40 M in Series C financing.
June 30, 2010... Calistoga Pharmaceuticals Inc (Calistoga), announced it has closed a $40 M Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners...